Regeneron Pharmaceuticals target price raised by Citigroup to $825 from $740
REGN•Citigroup raised its target price for Regeneron Pharmaceuticals to $825 from $740.
Related News
NPK International Inc.: B. Riley cuts target price to $15 from $21
NPKI•
America's Car-Mart secures loan default waiver extension through Nov. 4, 2026
CRMT•
CRISPR Therapeutics names Siva Sakhamuri chief technical officer
CRSP•
Nova to host investor day
NVMI•
Carlyle provides $225 million financing to Kingbee for fleet expansion
CG•